Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA.
Company profile
Website
CEO
John Alexander Martin
Employees
Incorporated
Location
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
1 Aug 19
EFFECT
Notice of effectiveness
1 Aug 19
25-NSE
Exchange delisting
31 Jul 19
6-K
Current report (foreign)
31 Jul 19
POS AM
Prospectus update (post-effective amendment)
30 Jul 19
6-K
Court sanction of Scheme of Arrangement; Acquisition expected to become effective 31 July 2019
30 Jul 19
6-K
Current report (foreign)
19 Jul 19
6-K
Current report (foreign)
8 Jul 19
6-K
Current report (foreign)
5 Jul 19
6-K
Realm announces updated expected timetable of principal events in connection with the Acquisition by Essa
2 Jul 19
Institutional ownership, Q4 2019
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Proequities | 0.00 | $0.00 |